IDRI’s role is to determine whether ingredients known as adjuvants can be added to the vaccine to magnify its immunizing effect. If the adjuvants work, they could reduce the amount of vaccine needed per dose, said Corey Casper, IDRI’s CEO.
“We’ve pioneered probably the largest collection of these adjuvant formulations that can be safely added to vaccines to increase their efficacy, to increase their potency, to increase the ability to store them,” Casper told GeekWire. “They’ve really revolutionized vaccines.”
Most recently, adjuvants have provided a boost to GlaxoSmithKline’s Shingrix vaccine for shingles as well as a variety of vaccine candidates for tuberculosis, Casper said. Baylor and PATH are hoping they’ll do the same for their coronavirus vaccine.
Stallergenes Anergis & Mymetics can reduce inflammation in the lungs
or should I say Mymetics & Anergis can
Stallergenes sure has that birch pollen extract thing going on, that's the big reason VC went w/ them besides the other Anergis team members history w/ them